Main navigation
You are here
- Home
- Investors
- Presentations & webcasts
2003 Presentations
29 January 2004
2 October 2003
2003 full year results presentation
2 October 2003
2003 annual business review
US pharma environment - (PDF 1,222 kb)
Pipeline review - (PDF 287 kb)
24 July 2003
2003 half year results presentation
R&D pipeline table - (PDF 105 kb)
2003 other presentations
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD - Stockholm
-
310.10 SEK
At 21-Nov-2009 10:43 GMT
Detailed share priceStock symbol - AZN
On LSE, NYSE and OMX
Introduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:
